Seven eyes were lost to follow up beyond one week and were excluded from further analysis. The follow-up period for the patients with endophthalmitis was 586.14 ± 825.15 days. Table 4 shows the overall visual outcomes in various subgroups. Overall, 13 (34.2%) patients had a favorable visual outcome (i.e., best-corrected visual acuity [BCVA] > 5/200), and 24 (63.2%) had an unfavorable visual outcome (BCVA < 5/200). Overall, 5 (13.1%) and 10 (26.3%) patients had a vision of better than or equal to 6/18 and 6/60, respectively. The globe could be salvaged in 27 (71.0%) cases. The most common cause of poor vision was macular pathology, including scar, epiretinal membrane, and thinning across the three groups. No statistically significant difference was observed in outcome in different subgroups: gram negative versus gram positive; those who had tamponade versus those who did not have tamponade. However, cases with positive culture (particularly gram-negative and fungus-infected) had more unfavorable outcomes (P < 0.05). Although no significant difference was observed in the clinical presentation between the groups (P > 0.05), patients in the culture-positive group presented relatively early compared to the culture-negative group (75.0% vs. 66.7% at week 1). A higher proportion of patients in the culture-negative group were treated with only intraocular antibiotics (IOAB) compared to those in the culture-positive group (52.4% vs. 25.0%; P = 0.120).